Geneva Partners, LLC Perkinelmer Inc Transaction History

Geneva Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$120.35 - $160.53 $970,021 - $1.29 Million	-8,060 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$122.05 - $147.91 $461,959 - $559,839	-3,785 Reduced 31.95%	8,060 $1.16 Million
Q3 2020 Oct 28, 2020	BUY	$97.09 - $125.51 $1.15 Million - $1.49 Million	11,845 New	11,845 $1.49 Million
Q1 2020 Apr 27, 2020	SELL	$66.71 - $101.73 $858,757 - $1.31 Million	-12,873 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$79.44 - $98.79 $254,128 - $316,029	-3,199 Reduced 19.9%	12,873 $1.1 Million
Q2 2019 Jul 31, 2019	SELL	$84.06 - $101.12 $18,913 - $22,752	-225 Reduced 1.38%	16,072 $1.55 Million
Q1 2019 May 10, 2019	BUY	$72.79 - $97.5 $25,403 - $34,027	349 Added 2.19%	16,297 $1.57 Million
Q4 2018 Jan 30, 2019	SELL	$71.87 - $97.02 $7,474 - $10,090	-104 Reduced 0.65%	15,948 $1.25 Million
Q3 2018 Oct 23, 2018	SELL	$72.59 - $97.27 $72 - $97	-1 Reduced 0.01%	16,052 $1.56 Million
Q2 2018 Aug 09, 2018	SELL	$72.1 - $79.39 $151,554 - $166,877	-2,102 Reduced 11.58%	16,053 $1.18 Million
Q1 2018 May 08, 2018	SELL	$72.06 - $82.75 $108,090 - $124,125	-1,500 Reduced 7.63%	18,155 $1.38 Million
Q4 2017 Feb 08, 2018	SELL	$69.36 - $73.84 $138,720 - $147,680	-2,000 Reduced 9.24%	19,655 $1.44 Million
Q3 2017 Nov 08, 2017	BUY	$62.95 - $69.48 $1.36 Million - $1.5 Million	21,655	21,655 $1.49 Million

571

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.